These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31948941)

  • 1. Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
    Gartrell-Corrado RD; Chen AX; Rizk EM; Marks DK; Bogardus MH; Hart TD; Silverman AM; Bayan CY; Finkel GG; Barker LW; Komatsubara KM; Carvajal RD; Horst BA; Chang R; Monod A; Rabadan R; Saenger YM
    Cancer Res; 2020 Mar; 80(5):1078-1087. PubMed ID: 31948941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Analysis of Immune Infiltrates in Primary Melanoma.
    Gartrell RD; Marks DK; Hart TD; Li G; Davari DR; Wu A; Blake Z; Lu Y; Askin KN; Monod A; Esancy CL; Stack EC; Jia DT; Armenta PM; Fu Y; Izaki D; Taback B; Rabadan R; Kaufman HL; Drake CG; Horst BA; Saenger YM
    Cancer Immunol Res; 2018 Apr; 6(4):481-493. PubMed ID: 29467127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic genes and construction of a novel gene signature in the skin melanoma based on the tumor microenvironment.
    Yingjuan W; Li Z; Wei C; Xiaoyuan W
    Medicine (Baltimore); 2021 May; 100(21):e26017. PubMed ID: 34032721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma.
    Tsagozis P; Augsten M; Zhang Y; Li T; Hesla A; Bergh J; Haglund F; Tobin NP; Ehnman M
    Cancer Immunol Immunother; 2019 Jun; 68(6):927-936. PubMed ID: 30879106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the tumor immune microenvironment in synovial sarcoma.
    Oike N; Kawashima H; Ogose A; Hotta T; Hatano H; Ariizumi T; Sasaki T; Yamagishi T; Umezu H; Endo N
    Cancer Sci; 2018 Oct; 109(10):3043-3054. PubMed ID: 30133055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
    Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
    Failmezger H; Muralidhar S; Rullan A; de Andrea CE; Sahai E; Yuan Y
    Cancer Res; 2020 Mar; 80(5):1199-1209. PubMed ID: 31874858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
    Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
    Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
    Gartrell RD; Marks DK; Rizk EM; Bogardus M; Gérard CL; Barker LW; Fu Y; Esancy CL; Li G; Ji J; Rui S; Ernstoff MS; Taback B; Pabla S; Chang R; Lee SJ; Krolewski JJ; Morrison C; Horst BA; Saenger YM
    Clin Cancer Res; 2019 Apr; 25(8):2494-2502. PubMed ID: 30647081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
    Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
    J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8
    Katayama C; Yokobori T; Ozawa N; Suga K; Shiraishi T; Okada T; Osone K; Katoh R; Suto T; Motegi Y; Ogawa H; Sano A; Sakai M; Sohda M; Erkhem-Ochir B; Gombodorj N; Katayama A; Oyama T; Shirabe K; Kuwano H; Saeki H
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1364. PubMed ID: 33675293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular oncogene markers and their significance in cutaneous malignant melanoma.
    Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ
    Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
    Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
    Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.
    Hajiran A; Chakiryan N; Aydin AM; Zemp L; Nguyen J; Laborde JM; Chahoud J; Spiess PE; Zaman S; Falasiri S; Fournier M; Teer JK; Dhillon J; McCarthy S; Moran-Segura C; Katende EN; Sexton WJ; Koomen JM; Mulé J; Kim Y; Manley B
    Clin Exp Immunol; 2021 Apr; 204(1):96-106. PubMed ID: 33346915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients.
    De Logu F; Galli F; Nassini R; Ugolini F; Simi S; Cossa M; Miracco C; Gianatti A; De Giorgi V; Rulli E; Cossu A; Massi D; Mandalà M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33671367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy.
    Saraiva DP; Jacinto A; Borralho P; Braga S; Cabral MG
    Front Immunol; 2018; 9():2605. PubMed ID: 30555458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y; McCarthy C; Kalirai H; Coupland SE
    Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
    Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
    Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Thygesen HH; Jakobs PJ; Jóźwiak K; Heeren AM; de Jong J; Sanders J; Horenblas S; Jordanova ES
    Front Immunol; 2018; 9():1253. PubMed ID: 29942303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).
    Bretz AC; Parnitzke U; Kronthaler K; Dreker T; Bartz R; Hermann F; Ammendola A; Wulff T; Hamm S
    J Immunother Cancer; 2019 Nov; 7(1):294. PubMed ID: 31703604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.